Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nanolek

Nanolek?uq=AFYHfsyn
2011 FOUNDED
PRIVATE STATUS
201-300 EMPLOYEES
Corporate LATEST DEAL TYPE
3 FINANCING ROUNDS
Description

Operator of a biopharmaceutical company. The company has its own complete cycle production based on the good manufacturing practice (GMP) standards and specializes in the production of import-substituting and innovative pharmaceuticals, both in-house developed and invented with the attraction of international partners, with a focus on the prevention and treatment of socially significant diseases.

Website
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Butyrsky Val st., 68/70, 1
  • Business Center Baker Plaza, 4th Floor, Office 45
  • Moscow, 127055
  • Russia

+7 8 (000) 000-00-00

Nanolek Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Nanolek‘s full profile, request access.

Request full access to PitchBook

Nanolek Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Nanolek‘s full profile, request access.

Request full access to PitchBook

Nanolek Executive Team (3)

Name Title Board
Seat
Contact
Info
Mikhail Nekrasov Chief Executive Officer
Svetlana Efimova Deputy Chief Executive Officer, Supply & Project Management
Vladimir Khristenko President

Nanolek Board Members (1)

Name Representing Role Since Contact
Info
00000 0000000 Self Board Member 000 0000